RaminSedaghatHeratiMD

Infectious Disease • New York, NY

Physician

Join to view full profile

Dr. Herati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Herati's full profile

Already have an account?

Office
430 E 29th St
5th Floor Room 512
New York, NY 10016

Education & Training

University of Pennsylvania Health SystemFellowship, Infectious Disease, 2011 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
Washington University in St. Louis School of MedicineClass of 2008

Certifications & Licensure

NY State Medical License 2019 - 2026
PA State Medical License 2011 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Flu Vaccine Responses in the Setting of Melanoma Treatment Start of enrollment: 2017 Oct 20
Active, not recruiting
Phase 4

Publications & Presentations

PubMed

Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1CD8T cells.
Zhen Zhang, Marlene Langenbach, Sagar Sagar, Viktor Fetsch, Jonas Stritzker
Nature Immunology. 2024-12-19
1 citations
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
Sophie L Gray-Gaillard, Sabrina M Solis, Han M Chen, Clarice Monteiro, Grace Ciabattoni
Science Immunology. 2024-06-21
9 citations
Integrative multi-omics profiling in human decedents receiving pig heart xenografts.
Eloi Schmauch, Brian Piening, Maedeh Mohebnasab, Bo Xia, Chenchen Zhu
Nature Medicine. 2024-05-01

Journal Articles

Research Paper Deep Immune Profiling by Mass Cytometry Links Human T and NK Cell Differentiation and Cytotoxic Molecule Expression Patterns
Ramin Herati, MD, ScienceDirect
Research Paper Deep Immune Profiling by Mass Cytometry Links Human T and NK Cell Differentiation and Cytotoxic Molecule Expression Patterns
Ramin Sedaghat Herati, Kyong-Mi Chang, ScienceDirect

Press Mentions

Patients Recovered from COVID-19 May Require Just One Dose of mRNA VaccineMarch 9th, 2021
Patients Recovered from COVID-19 May Require Just One Dose of mRNA VaccineMarch 9th, 2021
Penn Team Tracks Rare T Cells in Blood to Better Understand Annual Flu VaccineFebruary 18th, 2017